24-10-2014

24
th
October, 2014 Volume No.: 38 Issue No.: 03
Vision
TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD
OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE BASED
LEARNING AND PRACTICE
Contents
Message from PRINCIPAL
Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking
News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive
GNIPST Photo Gallery
For your comments/contribution
OR For Back-Issues,
mailto:gnipstbulletin@gmail.com
GURU NANAK INSTITUTE OF PHARMACEUTICAL
SCIENCE AND TECHNOLOGY

We

b

si

t

e

:



ht

t

p:

/

/

gni

ps

t.

a

c.

i

n


24-10-2014
MESSAGE FROM PRINCIPAL

"It can happen. It does happen.
But it can't happen if you quit." Lauren Dane.
We are what we repeatedly do.
Excellence then is not an act, but a habit. Aristotle
It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.
Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.
I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.
It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.
The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.
The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.
I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.
My best wishes to all.
Dr. A. Sengupta
Click here to go at the top
1
24-10-2014

EDITORIAL BOARD
CHIEF EDITOR DR. ABHIJIT SENGUPTA
EDITOR MS. JEENATARA BEGUM
ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE
Avicenna The Persian Galen:
Among the brilliant contributors to the sciences of Pharmacy and
Medicine during the Arabian era was one genius who seems to
stand for his time - the Persian, Ibn Sina (about 980-1037 A.D.),
called Avicenna by the Western world. Pharmacist, poet,
physician, philosopher and diplomat, Avicenna was an intellectual
giant, a favorite of Persian princes and rulers. He wrote in Arabic,
often while secluded in the home of an apothecary friend. His
pharmaceutical teachings were accepted as authority in the West
until the 17th century; and still are dominant influences in the
Orient.
NEWS UPDATE
Without swift influx of substantial aid, Ebola
epidemic in Africa poised to explode: (23
rd

October, 2014)
The Ebola virus disease epidemic already devastating swaths of
West Africa will likely get far worse in the coming weeks and
months unless international commitments are significantly and
immediately increased, new research predicts.
Designer 'barrel' proteins created: (23
rd

October, 2014)
Designer proteins that expand on nature's own repertoire, created
by a team of chemists and biochemists, are described in a new
paper. Proteins are long linear molecules that fold up to form well-
Click here to go at the top

2
24-10-2014

defined 3D shapes. These 3D molecular architectures are essential
for biological functions such as the elasticity of skin, the digestion
of food, and the transport of oxygen in blood.
A gut bacterium that attacks dengue and
malaria pathogens and their mosquito vectors:
(23
rd
October, 2014)
Just like those of humans, insect guts are full of microbes, and the
microbiota can influence the insect's ability to transmit diseases. A
new study reports that a bacterium isolated from the gut of an
Aedes mosquito can reduce infection of mosquitoes by malaria
parasites and dengue virus. The bacterium can also directly inhibit
these pathogens in the test tube, and shorten the life span of the
mosquitoes that transmit both diseases.
Sleep difficulties common among toddlers with
psychiatric disorders: (23
rd
October, 2014)
Sleep difficulties -- particularly problems with falling asleep --
were very common among toddlers and preschool-aged children
who were receiving clinical treatment for a wide range of
psychiatric disorders, a study has found. "This study is a great
reminder that it's critical for mental health providers working with
young children and their families to ask about children's sleep,"
said one expert.
Cancer exosome 'micro factories' aid in cancer
progression: (23
rd
October, 2014)
Exosomes, tiny, virus-sized particles released by cancer cells, can
bioengineer micro-RNA molecules resulting in tumor growth.
They do so with the help of proteins, such as one named Dicer,
scientists have discovered.
YEATS protein potential therapeutic target for
cancer: (23
rd
October, 2014)
Federal Express and UPS are no match for the human body when
it comes to distribution. There exists in cancer biology an
Click here to go at the top

3
24-10-2014

impressive packaging and delivery system that influences whether
your body will develop cancer or not, scientists say. Researchers
have announced findings indicating a possible new way of
manipulating chromatin and its histones through a protein reader
known as the YEATS domain protein, providing new hope for
cancer treatment.
Paper-based synthetic gene networks could
enable rapid detection of ebola and other
viruses: (23
rd
October, 2014)
Synthetic gene networks hold great potential for broad
biotechnology and medical applications, but so far they have been
limited to the lab. A study reveals a new method for using
engineered gene circuits beyond the lab, allowing researchers to
safely activate the cell-free, paper-based system by simply adding
water. The low-cost, easy-to-use platform could enable the rapid
detection of different strains of deadly viruses such as Ebola.
Gene that once aided survival in Arctic found to
have negative impact on health today: (23
rd

October, 2014)
In individuals living in the Arctic, researchers have discovered a
genetic variant that arose thousands of years ago and likely
provided an evolutionary advantage for processing high-fat diets or
for surviving in a cold environment; however, the variant also
seems to increase the risk of hypoglycemia, or low blood sugar, and
infant mortality in today's northern populations. The findings
provide an example of how an initially beneficial genetic change
could be detrimental to future generations.
Experimental breast cancer drug holds promise
in combination therapy for Ewing sarcoma: (23
rd

October, 2014)
Ewing sarcoma tumors disappeared and did not return in more
than 70 percent of mice treated with combination therapy that
Click here to go at the top

4
24-10-2014
included drugs from a family of experimental agents developed to
fight breast cancer, report researchers.
Thyroid cancer genome analysis finds markers of
aggressive tumors: (23
rd
October, 2014)
A new comprehensive analysis of thyroid cancer from The Cancer
Genome Atlas Research Network has identified markers of
aggressive tumors, which could allow for better targeting of
appropriate treatments to individual patients.
For detail mail to editor
KNOWLEDGE BASED ARTICLE
Influenza
Influenza, commonly known as "the flu", is an infectious
disease of birds and mammals caused by RNA viruses of the
family Orthomyxoviridae, the influenza viruses. The most
common symptoms are chills, fever, runny nose, sore throat, muscle
pains, headache (often severe), coughing,
weakness/fatigue and general discomfort. Although it is often
confused with other influenza-like illnesses, especially the common
cold, influenza is a more severe disease. Influenza may
produce nausea and vomiting, particularly in children, but these
symptoms are more common in unrelated forms of gastroenteritis,
which are sometimes inaccurately referred to as "stomach flu" or
"24-hour flu".
Typically, influenza is transmitted through the air by coughs or
sneezes, creating an aerosol containing the virus. Influenza can also
be transmitted by direct contact with bird droppings or nasal
secretions, or through contact with contaminated surfaces.
Airborne aerosols have been thought to cause most infections,
although which means of transmission is most important is not
absolutely clear. Influenza viruses can be inactivated
by sunlight, disinfectants and detergents.

As the virus can be
Click here to go at the top
5
24-10-2014

inactivated by soap, frequent hand washing reduces the risk of
infection. Flu can occasionally lead to pneumonia, either direct viral
pneumonia or secondary bacterial pneumonia, even for persons
who are usually very healthy. In particular it is a warning sign if a
child (or presumably an adult) seems to be getting better and then
relapses with a high fever as this relapse may be bacterial
pneumonia. Another warning sign is if the person starts to have
trouble breathing.
Signs and Syndrome
Approximately 33% of people with influenza are asymptomatic.
Symptoms of influenza can start quite suddenly one to two days
after infection. Usually the first symptoms are chills or a chilly
sensation, but fever is also common early in the infection, with
body temperatures ranging from 38 to 39 C (approximately 100 to
103 F). Many people are so ill that they are confined to bed for
several days, with aches and pains throughout their bodies, which
are worse in their backs and legs. Symptoms of influenza may
include:
Fever and extreme coldness (chills shivering, shaking (rigor))
Cough
Nasal congestion
Runny nose
Sneezing
Body aches, especially joints and throat
Fatigue
Headache
Irritated, watering eyes
Reddened eyes, skin (especially face), mouth, throat and nose
Petechial rash
In children, gastrointestinal symptoms such
as diarrhea and abdominal pain, (may be severe in children with
influenza B) It can be difficult to distinguish between the common
cold and influenza in the early stages of these infections
,
but a flu
can be identified by a high fever with a sudden onset and extreme
fatigue. Influenza is a mixture of symptoms of common cold
Click here to go at the top

6
24-10-2014

and pneumonia, body ache, headache, and fatigue. Diarrhea is not
normally a symptom of influenza in adults
,
although it has been
seen in some human cases of the H5N1 "bird flu
"
and can be a
symptom in children. The symptoms most reliably seen in
influenza are shown in the table to the right.
Since antiviral drugs are effective in treating influenza if given early
(see treatment section, below), it can be important to identify
cases early. Of the symptoms listed above, the combinations of
fever with cough, sore throat and/or nasal congestion can improve
diagnostic accuracy. Two decision analysis studies suggest
that during local outbreaksof influenza, the prevalence will be over
70%, and thus patients with any of these combinations of
symptoms may be treated with neuraminidase inhibitors without
testing. Even in the absence of a local outbreak, treatment may be
justified in the elderly during the influenza season as long as the
prevalence is over 15%.
The available laboratory tests for influenza continue to improve.
The United States Centers for Disease Control and
Prevention (CDC) maintains an up-to-date summary of available
laboratory tests. According to the CDC, rapid diagnostic tests have
a sensitivity of 7075% and specificity of 9095% when compared
with viral culture. These tests may be especially useful during the
influenza season (prevalence=25%) but in the absence of a local
outbreak, or peri-influenza season (prevalence=10%).
On the more serious side, influenza can occasionally cause either
direct viral or secondary bacterial pneumonia. The obvious
symptom is trouble breathing. In addition, if a child (or
presumably an adult) seems to be getting better and then relapses
with a high fever, that is a danger sign since this relapse can be
bacterial pneumonia.
Virology
Types of virus:
Structure of the influenza virion. The hemagglutinin (HA)
andneuraminidase(NA) proteins are shown on the surface of the
particle. The viral RNAs that make up thegenome are shown as red
Click here to go at the top

7
24-10-2014
coils inside the particle and bound to Ribonuclear
Proteins (RNPs).
In virus classification influenza viruses are RNA viruses that make
up three of the five genera of the family Orthomyxoviridae:
Influenzavirus A
Influenzavirus B
Influenzavirus C
These viruses are only distantly related to the human parainfluenza
viruses, which are RNA viruses belonging to
the paramyxovirus family that are a common cause of respiratory
infections in children such as croup, but can also cause a disease
similar to influenza in adults.
Influenzavirus A
This genus has one species, influenza A virus. Wild aquatic birds
are the natural hosts for a large variety of influenza A.
Occasionally, viruses are transmitted to other species and may
then cause devastating outbreaks in domestic poultry or give rise
to human influenza pandemics. The type A viruses are the most
virulent human pathogens among the three influenza types and
cause the most severe disease. The influenza A virus can be
subdivided into different serotypes based on the antibody response
to these viruses. The serotypes that have been confirmed in
humans, ordered by the number of known human pandemic
deaths, are:
H1N1, which caused Spanish Flu in 1918, and Swine Flu in 2009
H2N2, which caused Asian Flu in 1957
H3N2, which caused Hong Kong Flu in 1968
H5N1, which caused Bird Flu in 2004
H7N7, which has unusual zoonotic potential
H1N2, endemic in humans, pigs and birds
H9N2
H7N2
H7N3
H10N7
H7N9
Click here to go at the top
8
24-10-2014

Influenzavirus B

This genus has one species, influenza B virus. Influenza B almost
exclusively infects humans and is less common than influenza A.
The only other animals known to be susceptible to influenza B
infection are the seal and the ferret. This type of influenza mutates
at a rate 23 times slower than type A and consequently is less
genetically diverse, with only one influenza B serotype. As a result
of this lack of antigenic diversity, a degree of immunity to influenza
B is usually acquired at an early age. However, influenza B mutates
enough that lasting immunity is not possible. This reduced rate of
antigenic change, combined with its limited host range (inhibiting
cross species antigenic shift), ensures that pandemics of influenza
B do not occur.
Influenzavirus C
This genus has one species, influenza C virus, which infects
humans, dogs and pigs, sometimes causing both severe illness and
local epidemics. However, influenza C is less common than the
other types and usually only causes mild disease in children.
Structure, properties, and subtype nomenclature:
Influenzaviruses A, B and C are very similar in overall
structure. The virus particle is 80120 nanometers in diameter and
usually roughly spherical, although filamentous forms can
occur. These filamentous forms are more common in influenza C,
which can form cordlike structures up to 500 micrometers long on
the surfaces of infected cells.
[52]
However, despite these varied
shapes, the viral particles of all influenza viruses are similar in
composition. These are made of a viral envelope containing two
main types of glycoproteins, wrapped around a central core. The
central core contains the viral RNAgenome and other viral proteins
that package and protect this RNA. RNA tends to be single
stranded but in special cases it is double. Unusually for a virus, its
genome is not a single piece of nucleic acid; instead, it contains
seven or eight pieces of segmented negative-sense RNA, each piece
of RNA containing either one or two genes, which code for a gene
Click here to go at the top

9
24-10-2014

product (protein). For example, the influenza A genome contains 11
genes on eight pieces of RNA, encoding for
11 proteins: hemagglutinin (HA), neuraminidase (NA), nucleoprotei
n (NP), M1, M2, NS1, NS2(NEP: nuclear export protein), PA, PB1
(polymerase basic 1), PB1-F2 and PB2.
Hemagglutinin (HA) and neuraminidase (NA) are the two large
glycoproteins on the outside of the viral particles. HA is
a lectin that mediates binding of the virus to target cells and entry
of the viral genome into the target cell, while NA is involved in the
release of progeny virus from infected cells, by cleaving sugars that
bind the mature viral particles. Thus, these proteins are targets
for antiviral drugs. Furthermore, they are antigens to
which antibodies can be raised. Influenza A viruses are classified
into subtypes based on antibody responses to HA and NA. These
different types of HA and NA form the basis of
the H and N distinctions in, for example, H5N1. There are 16 H and 9
N subtypes known, but only H 1, 2 and 3, and N 1 and 2 are
commonly found in humans.
Prevention
Vaccination:
The influenza vaccine is recommended by the World Health
Organization and United States Centers for Disease Control and
Prevention for high-risk groups, such as children, the elderly,
health care workers, and people who have chronic illnesses such
as asthma, diabetes, heart disease, or are immuno-compromised
among others. In healthy adults it is modestly effective in
decreasing the amount of influenza-like symptoms in a
population. Evidence is supportive of a decreased rate of influenza
in children over the age of two. In those with chronic obstructive
pulmonary disease vaccination reduces exacerbations, it is not
clear if it reduces asthma exacerbations. Evidence supports a
lower rate of influenza-like illness in many groups who are
immunocompromised such as those with: HIV/AIDS, cancer, and
post organ transplant. In those at high risk immunization may
reduce the risk of heart disease. Whether immunizing health care
Click here to go at the top

10
24-10-2014

workers effects patient outcomes is controversial with some
reviews finding insufficient evidence and others finding tentative
evidence.
Due to the high mutation rate of the virus, a particular influenza
vaccine usually confers protection for no more than a few years.
Every year, the World Health Organization predicts which strains
of the virus are most likely to be circulating in the next year
(see Historical annual reformulations of the influenza vaccine),
allowingpharmaceutical companies to develop vaccines that will
provide the best immunity against these strains. The vaccine is
reformulated each season for a few specific flu strains but does not
include all the strains active in the world during that season. It
takes about six months for the manufacturers to formulate and
produce the millions of doses required to deal with the seasonal
epidemics; occasionally, a new or overlooked strain becomes
prominent during that time. It is also possible to get infected just
before vaccination and get sick with the strain that the vaccine is
supposed to prevent, as the vaccine takes about two weeks to
become effective.
Vaccines can cause the immune system to react as if the body were
actually being infected, and general infection symptoms (many
cold and flu symptoms are just general infection symptoms) can
appear, though these symptoms are usually not as severe or long-
lasting as influenza. The most dangerous adverse effect is a
severe allergic reaction to either the virus material itself or residues
from the hen eggs used to grow the influenza; however, these
reactions are extremely rare.
The cost-effectiveness of seasonal influenza vaccination has been
widely evaluated for different groups and in different settings.

It as
generally been found to be a cost-effective intervention, especially
in children and the elderly, however the results of economic
evaluations of influenza vaccination have often been found to be
dependent on key assumptions.
Click here to go at the top

11
24-10-2014

Infection control:
Reasonably effective ways to reduce the transmission of influenza
include good personal health and hygiene habits such as: not
touching your eyes, nose or mouth; frequent hand washing (with
soap and water, or with alcohol-based hand rubs); covering
coughs and sneezes; avoiding close contact with sick people; and
staying home yourself if you are sick. Avoiding spitting is also
recommended. Although face masks might help prevent
transmission when caring for the sick, there is mixed evidence on
beneficial effects in the community. Smoking raises the risk of
contracting influenza, as well as producing more severe disease
symptoms.
Since influenza spreads through both aerosols and contact with
contaminated surfaces, surface sanitizing may help prevent some
infections. Alcohol is an effective sanitizer against influenza
viruses, whilequaternary ammonium compounds can be used with
alcohol so that the sanitizing effect lasts for longer. In hospitals,
quaternary ammonium compounds and bleach are used to sanitize
rooms or equipment that have been occupied by patients with
influenza symptoms. At home, this can be done effectively with a
diluted chlorine bleach.
During past pandemics, closing schools, churches and theaters
slowed the spread of the virus but did not have a large effect on the
overall death rate. It is uncertain if reducing public gatherings, by
for example closing schools and workplaces, will reduce
transmission since people with influenza may just be moved from
one area to another; such measures would also be difficult to
enforce and might be unpopular.

When small numbers of people
are infected, isolating the sick might reduce the risk of
transmission.


Treatment
People with the flu are advised to get plenty of rest, drink plenty of
liquids, avoid using alcohol and tobacco and, if necessary, take
medications such as acetaminophen (paracetamol) to relieve the
fever and muscle aches associated with the flu.

Children and
Click here to go at the top

12
24-10-2014

teenagers with flu symptoms (particularly fever) should avoid
taking aspirin during an influenza infection (especially influenza
type B), because doing so can lead to Reye's syndrome, a rare but
potentially fatal disease of the liver.

Since influenza is caused by a
virus, antibiotics have no effect on the infection; unless prescribed
for secondary infections such as bacterial pneumonia. Antiviral
medication may be effective, but some strains of influenza can
show resistance to the standard antiviral drugs and there is
concern about the quality of the research.
Antivirals:
The two classes of antiviral drugs used against influenza
are neuraminidase inhibitors (oseltamivir and zanamivir) and M2
protein inhibitors (adamantane derivatives).
Neuraminidase inhibitors:
Overall the benefits of neuraminidase inhibitors in those who are
otherwise healthy do not appear to be greater than the risks. There
does not appear to be any benefit in those with other health
problems. In those believed to have the flu they decreased the
length of time symptoms are present by slightly less than a day but
do not appear to affect the risk of complications such as needing
hospitalization orpneumonia.

Previous to 2013 the benefits were
unclear as the manufacturer (Roche) refused to release trial data
for independent analysis.
M2 inhibitors:
The antiviral drugs amantadine and rimantadine block a viral ion
channel (M2 protein) and prevent the virus from infecting
cells. These drugs are sometimes effective against influenza A if
given early in the infection but are ineffective against influenza B
viruses, which lack the M2 drug target.
[128]
Measured resistance to
amantadine and rimantadine in American isolates of H3N2 has
increased to 91% in 2005. This high level of resistance may be due
to the easy availability of amantadines as part of over-the-counter
cold remedies in countries such as China and Russia, and their use
to prevent outbreaks of influenza in farmed poultry. The CDC
Click here to go at the top

13
24-10-2014

recommended against using M2 inhibitors during the 200506
influenza season due to high levels of drug resistance.

Jeenatara Begum
Assistant Professor
GNIPST
DISEASE RELATED BREAKING NEWS
Chikungunya France: (23
rd
October, 2014)
On 21 October 2014, WHO was notified by the National IHR Focal
Point for France of 4 cases of chikungunya locally-acquired
infection in Montpellier, France. The cases were confirmed by
tests conducted by the French National Reference Laboratory for
arboviruses on 20 October 2014. This is the first time that locally-
acquired transmission of chikungunya has been detected in France
since 2010.
Read more

UPCOMING EVENTS
5
th
International Conference on Stem Cells and Cancer 2014, JNU
Convention Centre, New Delhi, India from 8-10 November, 2014

DRUGS UPDATES
U.S. FDA Accepts Filing Of NDA for
Empagliflozin/Metformin Fixed-Dose
Combination: (21
st
October, 2014)
The U.S. Food and Drug Administration (FDA) has accepted the
filing of a New Drug Application (NDA) for empagliflozin plus
immediate-release metformin hydrochloride fixed-dose
combination, an investigational compound being studied for the
treatment of adults with type 2 diabetes (T2D). Empagliflozin plus
metformin is part of the Boehringer Ingelheim and Eli Lilly and
Click here to go at the top

14
24-10-2014

Company (NYSE: LLY) Diabetes alliance portfolio. "Type 2
diabetes is a progressive condition, and many patients eventually
require multiple medications to manage their blood sugar," said
Christophe Arbet-Engels, M.D., Ph.D., vice president, metabolic-
clinical development and medical affairs, Boehringer Ingelheim
Pharmaceuticals, Inc. "The FDA's acceptance of the NDA for the
empagliflozin plus metformin fixed-dose combination brings us
one step closer to offering a potential new treatment option that
may help patients better manage their type 2 diabetes through one
pill that combines two distinct approaches to help control blood
sugar." Read more

CAMPUS NEWS
Congratulation to the winner of Cricket Tournament-B.Pharm 3rd
year, 2014
Runner up team-B.Sc and BHM, 2014
Congratulation to the highest run scorer of Cricket Tournament-
Tanmoy Das Biswas, B.Pharm 3rd year, 2014
Congratulation to the highest wicket taker of Cricket
Tournament-Subhodip Das, B.Pharm 3rd year, 2014
Congratulation to the winner of Carom Tournament (Boys)-
Sk. Abdul Salam, B.Pharm 2
nd
year, 2014
1st Runner up-Subhayan Dutta, M.Sc (Biotechnology Department)
2nd year, 2014
2nd Runner up-Nirupan Gupta, B.Pharm 1
st
year, 2014
Congratulation to the winner of Carom Tournament (Girls)-
Aishwarya Datta, B.Pharm 2
nd
year, 2014
1st Runner up-Krishnakali Basu, B.Pharm 3
rd
year, 2014
2nd Runner up-Rituparna Das, B.Pharm 3
rd
year, 2014
Congratulation to the winner of Chess Tournament (Boys)-
Basab Brata Dey, M.Sc (Biotechnology Department) 2
nd
year, 2014
1st Runner up-Ankit Chowdhury, B.Pharm 1
st
year, 2014
2nd Runner up-Smaranjeet Banik, B.Pharm 3
rd
year, 2014
Click here to go at the top

15
24-10-2014

Congratulation to the winner of Chess Tournament (Girls)-
Rituparna Das, B.Pharm 3
rd
year, 2014
1st Runner up-Varsa Srivastav, B.Sc(Bioptechnology Department)
1
st
year, 2014
2nd Runner up- Krishnakali Basu, B.Pharm 3
rd
year, 2014
The GNIPST Cricket Tournament, Carom Tournament and Chess
Tournament was held on 21
st
and 22
nd
October, 2014.
The Cultural Programme on Bijoya Dashami and Kali Puja was
held on 20
th
October, 2014
An exhibition on Photography and Painting was held on 20
th

October, 2014
Congratulation to the winner of Football Tournament-B.Pharm
3rd year, 2014
Runner up team-B.Pharm final year, 2014
Congratulation to the winner of Table Tennis Tournament-
Krishnakali Basu, B.Pharm 3rd year, 2014
1st Runner up-Aindrila Bhowmick, B.Pharm 2nd year, 2014
2nd Runner up-Sayani Banerjee, B.Pharm 2nd year, 2014
The GNIPST Football Tournament (for male students) and Table
Tennis tournament (for female students) was held on 25th and
26th September, 2014.
On 5
th
September, 2014 the students of GNIPST have arranged a
wonderful Teachers Day Programme. On behalf of all the teachers
of GNIPST I would like to thank our beloved students.
The Freshers welcome programme was held on 14
th
August, 2014.
Welcome 1
st
year students.
We congratulate the following M.Pharm. final year students who
have made their positions in different pharmaceutical companies.
Anirban Banerjee (Emami Ltd.)
Mahender Roy (Stadmed private Ltd.)
Click here to go at the top

16
24-10-2014

We congratulate the following B.Pharm. final year students for
their success.
Samadrita Mukherjee (Abbott India Ltd.)
Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)
Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition)
Avishek Naskar (Glaxo SmithKline-Marketing)
Bappaditya Manik (USV Limited)
Sarbani Das (Nutri Synapzz-Marketing)
Ankita Roy (Nutri Synapzz-Marketing)
Rahul Mitra (B M Pharmaceuticals-Production)
The following B.Pharm. final year students have qualified, GPAT-
2014. We congratulate them all.
Utsha Sinha
Satarupa Bhattacharya
Sandipan Sarkar
Purbali Chakraborty
Reminiscence, 2014(GNIPST Reunion) was held in College
campus on 2
nd
February,2014.
1
st
Annual Sports of GNIPST was held on 3
rd
February,2014 in
College campus ground.
An industrial tour and biodiversity tour was conducted in Sikkim
for B.Pharm and B.Sc. students under the supervision of Mr. Asis
Bala, Ms. Jeentara Begum and Ms. Moumita Chowdhury.
B.Pharm 3
rd
year won the GNIPST Football Champions trophy,
2013. B.Pharm 3
rd
year won the final match 1-0 against B.Pharm 2
nd

year. Deep Chakraborty was the only scorer of the final.



Click here to go at the top

17
24-10-2014

STUDENTS SECTION
WHO CAN ANSWER FIRST????
Maharaja manmatha nath
roychowdhary was the donator of which
indian sports trophy?
In which indian sports Kamla
Gupta trophy is awarded to runners up
team?

Answer of Previous Issues Questions:
A) Incheon
B) Appu
Congratulation Aindrila Bhowmick for your correct answer
Identify the lady

Answer of Previous Issues Image:
Tintu Lukka

Send your thoughts/
Quiz/Puzzles/games/write-ups or any other
contributions for Students Section&
answers of this Section at gnipstbulletin@gmail.com

Click here to go at the top

18
24-10-2014

EDITORS NOTE
It is a great pleasure for me to publish the 3
rd
issue of 38
th
Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
I wish all the GNIPST members and readers a very Happy Puja.

ARCHIVE
Students of GNIPST organized pre puja celebration programme,
Saaranya on 7
th
October, 2013 in college Auditorium.
GNIPST organized a garment distribution programme on 28
th

September, 2013 at Dakshineswar Kali Temple and Adyapith,
Kolkata. On this remarkable event about hundred people have
received garments. More than hundred students and most of the
faculties participated on that day with lot of enthusiasm.
GNIPST celebrated World Heart Day (29
th
September) and
Pharmacists Day (25
th
September) on 25
th
and 26
th
September,
Click here to go at the top

19
24-10-2014

2013 in GNIPST Auditorium. A seminar on Violence against
woman and female foeticide was held on GNIPST Auditorium on
25
th
September organized by JABALA Action Research
Organization. On 26
th
September an intra-college Oral and Poster
presentation competition related to World Pharmacists day and
Heart day was held in GNIPST. Ms. Purbali Chakraborty of
B.Pharm 4
th
year won the first prize in Oral Presentation. The
winner of Poster presentation was the group of Ms. Utsa Sinha,
Mr. Koushik Saha and Mr. Niladri Banerjee (B.Pharm 4
th
year). A
good number of students have participated in both the
competition with their valuable views.
Teachers day was celebrated on 5
th
September, 2013 by the
students of GNIPST in GNIPST Auditorium.
Azalea (exotic flower ) , the fresher welcome programme for
newcomers of GNIPST in the session 2013-14 was held on 8
th

August in GNIPST Auditorium.
One day seminar cum teachers development programme for
school teachers on the theme of Recent Trends of Life Sciences
in Higher Education organized by GNIPST held on 29
th
June,
2013 at GNIPST auditorium. The programme was inaugurated by
Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, Dy
Director of JIS Group and Dr. Abhijit Sengupta, Director cum
Principal of GNIPST with lamp lighting. The programme started
with an opening song performed by the B.Pharm students of this
institute. The seminar consists of a series of lectures, video
presentations and poster session. On the pre lunch session 4
lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata
Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty
Click here to go at the top

20
24-10-2014

respectively. On their presentation the speakers enlighten the
recent development of Pharmacy, Genetics and Microbiology and
their correlation with Life Sciences. On the post lunch session, Ms.
Saini Setua and Ms. Sanchari Bhattacharjee explained the recent
development and career opportunities in Biotechnology and
Hospital Management. The programme was concluded with
valedictory session and certificate distribution.
About 50 Higher secondary school teachers from different
schools of Kolkata and North& South 24 Parganas district of West
Bengal participated in this programme. A good interactive session
between participants and speakers was observed in the seminar.
The seminar was a great success with the effort of faculties, staffs
and students of our Institute. It was a unique discussion platform
for school teachers and professional of the emerging and newer
branches of Life Science.
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15
th
June, 2012. The program started with
a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural
Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.
GNIPST is now approved by AICTE and affiliated to WBUT for
conducting the two years post graduate course (M.Pharm)
in PHARMACOLOGY. The approved number of seat is 18.
The number of seats in B.Pharm. has been increased from 60 to
120.
Click here to go at the top

21
24-10-2014

AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.
Click here to go at the top

22